You've missed the point.
Technology and research keeps on advancing.
Never forget, the ReCell FDA trial initially began in 2006.
(You can look back through the historical announcements yourself)
In a rapidly advancing World, this is a long time ago.
It's been an eternity.
It's already been announced that rejigged FDA trials will not conclude until end of 2015.
AVH have already applied so that the results are fast tracked.
This can only mean early 2016, at best.
Whether the company has enough funds to survive until then will come into question more and more, as this approaches.
Meanwhile... other alternatives likes the one above will keep on advancing, ultimately diminishing the commercial value of ReCell.
And for some odd reason, people seem to assume ReCell FDA approval is some fait accompli.
Like anything in life, there are no guarantees there either.
Something totally unexpected could happen, which why products like these go through trials in the first place.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)